A randomized, double blind, placebo-controlled, parallel group study to demonstrate the subjective treatment effects of ramelteon on sleep using a post sleep questionnaire - Interactive Voice Response System (PSQ-IVRS) in an 'at-home setting' in an adult population with chronic insomnia

Trial Profile

A randomized, double blind, placebo-controlled, parallel group study to demonstrate the subjective treatment effects of ramelteon on sleep using a post sleep questionnaire - Interactive Voice Response System (PSQ-IVRS) in an 'at-home setting' in an adult population with chronic insomnia

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Jun 2016

At a glance

  • Drugs Ramelteon (Primary)
  • Indications Insomnia
  • Focus Therapeutic Use
  • Sponsors Takeda Global Research and Development Center
  • Most Recent Events

    • 25 Jun 2008 The expected completion date for this trial is now 1 Nov 2007.
    • 12 Jun 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 12 Jan 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top